Every winter, Canadian pediatric hospitals experience a wave of admissions linked to respiratory syncytial virus (RSV), one of the leading causes of hospitalization among children. These hospitalizations represent a major ...
Oct 4, 2023
0
10
Dr. Anna Banerji's ties to the Arctic run deep. She visited for the first time in 1995 to research respiratory syncytial virus (RSV) in Inuit babies. In 2004, she adopted an Inuit son and developed a close relationship with ...
Oct 2, 2023
0
1
New tests of a recently approved vaccine for respiratory syncytial virus—RSV—show the shot remains effective against a range of variants producing potent antibody responses against current and past strains, and may even ...
Influenza, respiratory syncytial virus (RSV), and COVID-19 are all part of the seasonal respiratory virus lineup. According to the Centers for Disease Control and Prevention (CDC), the upcoming fall and winter are expected ...
Sep 29, 2023
0
6
Researchers from the University of Pittsburgh and the National Institutes of Health (NIH) Vaccine Research Center have developed an improved way to test potential vaccines against bird flu. The report was published this week ...
Sep 29, 2023
0
29
COVID-19 hospitalizations in the United States were on the rise for weeks heading into mid-September, right as updated COVID-19 vaccines from Pfizer and Moderna started to be distributed across the country.
Sep 28, 2023
0
5
Just 23% of American adults say they 'definitely' will get the new COVID-19 vaccine, while another 23% say they will 'probably' get it, according to a new poll, which also finds interest in the shot falls along partisan lines.
Sep 27, 2023
0
1
Women may soon have a vaccine they can take during a pregnancy to help protect their newborn from respiratory syncytial virus (RSV).
Sep 25, 2023
0
1
A cancer drug could play an important role in limiting the damaging effects of lung disease in COVID-19 patients, thanks to new research at Hudson Institute of Medical Research.
Sep 18, 2023
0
29
National medicine regulator, the Food and Drug Administration (FDA), recently approved the world's first vaccines to prevent RSV, or respiratory syncytial virus, for infants and elderly adults.
Sep 14, 2023
0
12
